Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Functional characterization of 21 CYP2C19 allelic variants for clopidogrel 2-oxidation

The Pharmacogenomics Journal volume 15, pages 26–32 (2015)Cite this article

Subjects

Abstract

Genetic variations in cytochrome P450 2C19 (CYP2C19) contribute to interindividual variability in the metabolism of therapeutic agents such as clopidogrel. Polymorphisms in CYP2C19 are associated with large interindividual variations in the therapeutic efficacy of clopidogrel. This study evaluated the in vitro oxidation of clopidogrel by 21 CYP2C19 variants harboring amino acid substitutions. These CYP2C19 variants were heterologously expressed in COS-7 cells, and the kinetic parameters of clopidogrel 2-oxidation were estimated. Among the 21 CYP2C19 variants, 12 (that is, CYP2C19.5A, CYP2C19.5B, CYP2C19.6, CYP2C19.8, CYP2C19.9, CYP2C19.10, CYP2C19.14, CYP2C19.16, CYP2C19.19, CYP2C19.22, CYP2C19.24 and CYP2C19.25) showed no or markedly low activity compared with the wild-type protein CYP2C19.1B. This comprehensive in vitro assessment provided insights into the specific metabolic activities of CYP2C19 proteins encoded by variant alleles, and this may to be valuable when interpreting the results of in vivo studies.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  1. Zhou SF, Liu JP, Chowbay B . Polymorphism of human cytochrome P450 enzymes and its clinical impact. Drug Metab Rev 2009; 41: 89–295.

    Article  CAS  PubMed  Google Scholar 

  2. Zanger UM, Schwab M . Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation. Pharmacol Ther 2013; 138: 103–141.

    Article  CAS  PubMed  Google Scholar 

  3. Furuta T, Ohashi K, Kamata T, Takashima M, Kosuge K, Kawasaki T et al. Effect of genetic differences in omeprazole metabolism on cure rates for Helicobacter pylori infection and peptic ulcer. Ann Intern Med 1998; 129: 1027–1030.

    Article  CAS  PubMed  Google Scholar 

  4. Furuta T, Shirai N, Watanabe F, Honda S, Takeuchi K, Iida T et al. Effect of cytochrome P4502C19 genotypic differences on cure rates for gastroesophageal reflux disease by lansoprazole. Clin Pharmacol Ther 2002; 72: 453–460.

    Article  CAS  PubMed  Google Scholar 

  5. Mega JL, Close SL, Wiviott SD, Shen L, Hockett RD, Brandt JT et al. Cytochrome p-450 polymorphisms and response to clopidogrel. N Engl J Med 2009; 360: 354–362.

    Article  CAS  PubMed  Google Scholar 

  6. Maeda A, Ando H, Asai T, Ishiguro H, Umemoto N, Ohta M et al. Differential impacts of CYP2C19 gene polymorphisms on the antiplatelet effects of clopidogrel and ticlopidine. Clin Pharmacol Ther 2011; 89: 229–233.

    Article  CAS  PubMed  Google Scholar 

  7. Mao L, Jian C, Changzhi L, Dan H, Suihua H, Wenyi T et al. Cytochrome CYP2C19 polymorphism and risk of adverse clinical events in clopidogrel-treated patients: a meta-analysis based on 23,035 subjects. Arch Cardiovasc Dis 2013; 106: 517–527.

    Article  PubMed  Google Scholar 

  8. Kim KA, Park PW, Hong SJ, Park JY . The effect of CYP2C19 polymorphism on the pharmacokinetics and pharmacodynamics of clopidogrel: a possible mechanism for clopidogrel resistance. Clin Pharmacol Ther 2008; 84: 236–242.

    Article  CAS  PubMed  Google Scholar 

  9. Hiratsuka M . In vitro assessment of the allelic variants of cytochrome p450. Drug Metab Pharmacokinet 2012; 27: 68–84.

    Article  CAS  PubMed  Google Scholar 

  10. Kazui M, Nishiya Y, Ishizuka T, Hagihara K, Farid NA, Okazaki O et al. Identification of the human cytochrome P450 enzymes involved in the two oxidative steps in the bioactivation of clopidogrel to its pharmacologically active metabolite. Drug Metab Dispos 2010; 38: 92–99.

    Article  CAS  PubMed  Google Scholar 

  11. Pan Y, Mak JW, Ong CE . Heterologous expression of human cytochrome P450 (CYP) 2C19 in Escherichia coli and establishment of RP-HPLC method to serve as activity marker. Biomed Chromatogr 2013; 27: 859–865.

    Article  CAS  PubMed  Google Scholar 

  12. Lewis DF . The CYP2 family: models, mutants and interactions. Xenobiotica 1998; 28: 617–661.

    Article  CAS  PubMed  Google Scholar 

  13. Wang H, An N, Gao Y, Liu D, Bian T, Zhu J et al. Evaluation of the effects of 20 nonsynonymous single nucleotide polymorphisms of CYP2C19 on S-mephenytoin 4'-hydroxylation and omeprazole 5'-hydroxylation. Drug Metab Dispos 2011; 39: 830–837.

    Article  CAS  PubMed  Google Scholar 

  14. Ibeanu GC, Goldstein JA, Meyer U, Benhamou S, Bouchardy C, Dayer P et al. Identification of new human CYP2C19 alleles (CYP2C19*6 and CYP2C19*2B) in a Caucasian poor metabolizer of mephenytoin. J Pharmacol Exp Ther 1998; 286: 1490–1495.

    CAS  PubMed  Google Scholar 

  15. Bridges A, Gruenke L, Chang YT, Vakser IA, Loew G, Waskell L . Identification of the binding site on cytochrome P450 2B4 for cytochrome b5 and cytochrome P450 reductase. J Biol Chem 1998; 273: 17036–17049.

    Article  CAS  PubMed  Google Scholar 

  16. Straub P, Ramarao MK, Kemper B . Preference for aromatic substitutions at tryptophan-120, which is highly conserved and a potential mediator of electron transfer in cytochrome P450 2C2. Biochem Biophys Res Commun 1993; 197: 433–439.

    Article  CAS  PubMed  Google Scholar 

  17. Hichiya H, Tanaka-Kagawa T, Soyama A, Jinno H, Koyano S, Katori N et al. Functional characterization of five novel CYP2C8 variants, G171S, R186X, R186G, K247R, and K383N, found in a Japanese population. Drug Metab Dispos 2005; 33: 630–636.

    Article  CAS  PubMed  Google Scholar 

  18. Zhou Q, Yu XM, Lin HB, Wang L, Yun QZ, Hu SN et al. Genetic polymorphism, linkage disequilibrium, haplotype structure and novel allele analysis of CYP2C19 and CYP2D6 in Han Chinese. Pharmacogenomics J 2009; 9: 380–394.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This work was supported by the Japan Society for the Promotion of Science (KAKENHI 23659070), Smoking Research Foundation, Takeda Science Foundation and Japan Research Foundation for Clinical Pharmacology. We thank the Biomedical Research Core of Tohoku University Graduate School of Medicine for technical support.

Author information

Authors and Affiliations

  1. Laboratory of Pharmacotherapy of Life-Style Related Diseases, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan

    M Takahashi, T Saito, M Ito, C Tsukada, Y Katono, H Hosono, N Hirasawa & M Hiratsuka

  2. Department of Pharmacy, Tohoku University Hospital, Sendai, Japan

    M Maekawa, M Shimada & N Mano

  3. Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Japan

    A Oda

Authors
  1. M Takahashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. T Saito
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M Ito
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. C Tsukada
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Y Katono
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. H Hosono
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. M Maekawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. M Shimada
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. N Mano
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. A Oda
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. N Hirasawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. M Hiratsuka
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M Hiratsuka.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Additional information

Supplementary Information accompanies the paper on the The Pharmacogenomics Journal website

Supplementary information

PowerPoint slides

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Takahashi, M., Saito, T., Ito, M. et al. Functional characterization of 21 CYP2C19 allelic variants for clopidogrel 2-oxidation. Pharmacogenomics J 15, 26–32 (2015). https://doi.org/10.1038/tpj.2014.30

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/tpj.2014.30

This article is cited by

Search

Advanced search

Quick links